Prognostication in Myelofibrosis: Integrating Genetics into Routine Practice

This overview of the risk stratification landscape for MPNs discusses how genetic research has changed prognostic scoring systems, including the creation of two new risk stratification systems for primary and secondary myelofibrosis: MIPSS70 and MYSEC-PM.

 HemOnc Today

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.